CAREDX, INC. Inventory, Work in Process, Gross
CAREDX, INC. (CDNA) had Inventory, Work in Process, Gross of $2.81 million as of 2021-09-30, per its 10-Q filed 2021-10-28.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2021-10-28
- 2021-09-30: Inventory, Work in Process, Gross $2.81M.
- 2021-06-30: Inventory, Work in Process, Gross $3.10M.
- 2021-03-31: Inventory, Work in Process, Gross $3.21M.
- 2020-12-31: Inventory, Work in Process, Gross $2.94M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2021-09-30 | $2.81M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $3.10M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $3.21M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $2.94M 10-Q · filed 2021-10-28 |
| 2020-09-30 | $2.52M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $1.95M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $1.69M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $1.19M 10-K · filed 2021-02-24 |
| 2019-09-30 | $1.01M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $940.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $811.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $651.00K 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.27M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.55M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.43M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.47M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |